Mereo BioPharma Group PLC ADR (MREO) — Working Capital to Net Assets Ratio
Mereo BioPharma Group PLC ADR (MREO) has a Working Capital to Net Assets ratio of 96.8% as of June 2026. Working capital of $27.72 Million (current assets of $33.40 Million minus current liabilities of $5.68 Million) is measured against net assets of $28.65 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See defensive interval ratio of Mereo BioPharma Group PLC ADR to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Mereo BioPharma Group PLC ADR Working Capital to Net Assets (2015–2025)
This chart shows how Mereo BioPharma Group PLC ADR's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the ratio stands at 96.8%, reflecting working capital of $27.72 Million against net assets of $28.65 Million USD. For the complete balance sheet picture, see MREO current and non-current assets.
Annual Working Capital to Net Assets for Mereo BioPharma Group PLC ADR (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Mereo BioPharma Group PLC ADR from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check MREO financial resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 99.5% | $40.72 Million | $40.92 Million | $45.02 Million | $4.30 Million | ▼ -0.4 pp |
| 2024 | 99.9% | $60.91 Million | $60.97 Million | $74.76 Million | $13.85 Million | ▼ -7.5 pp |
| 2023 | 107.4% | $54.27 Million | $50.54 Million | $63.76 Million | $9.49 Million | ▲ +8.5 pp |
| 2022 | 98.9% | $50.82 Million | $51.40 Million | $75.20 Million | $24.38 Million | ▲ +0.3 pp |
| 2021 | 98.6% | $117.36 Million | $119.01 Million | $134.32 Million | $16.96 Million | ▲ +240.0 pp |
| 2020 | -141.3% | $28.94 Million | $-20.47 Million | $40.65 Million | $11.71 Million | ▼ -142.7 pp |
| 2019 | 1.4% | $737.86K | $53.33 Million | $40.32 Million | $39.58 Million | ▼ -54.5 pp |
| 2018 | 55.9% | $18.32 Million | $32.77 Million | $34.50 Million | $16.18 Million | ▼ -29.8 pp |
| 2017 | 85.7% | $53.56 Million | $62.48 Million | $63.18 Million | $9.62 Million | ▲ +13.1 pp |
| 2016 | 72.6% | $57.57 Million | $79.26 Million | $60.78 Million | $3.21 Million | ▼ -4.6 pp |
| 2015 | 77.3% | $78.46 Million | $101.54 Million | $81.28 Million | $2.82 Million | — |